Last reviewed · How we verify
Аrgon-oxygen breathing mixture
An argon-oxygen breathing mixture enhances tissue oxygenation and reduces hypoxia by delivering a gas combination with optimized oxygen availability and inert gas properties.
An argon-oxygen breathing mixture enhances tissue oxygenation and reduces hypoxia by delivering a gas combination with optimized oxygen availability and inert gas properties. Used for Resuscitation and post-resuscitation care, Hypoxic-ischemic encephalopathy.
At a glance
| Generic name | Аrgon-oxygen breathing mixture |
|---|---|
| Sponsor | Negovsky Reanimatology Research Institute |
| Drug class | Medical gas mixture |
| Modality | Small molecule |
| Therapeutic area | Critical Care / Resuscitation |
| Phase | Phase 3 |
Mechanism of action
Argon is a noble gas with potential neuroprotective properties, while the oxygen component ensures adequate tissue perfusion. The mixture may work by reducing oxidative stress, improving microcirculation, and providing cytoprotective effects during ischemic or hypoxic conditions. This combination is investigated for resuscitation and critical care applications where rapid reoxygenation and neuroprotection are needed.
Approved indications
- Resuscitation and post-resuscitation care
- Hypoxic-ischemic encephalopathy
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: